Endothelial permeability and VE-cadherin A wacky comradeship

Cell Adhesion and Migration

Volumn 7, Issue 6, 2013, Pages 465-471

  Gavard, Julie ^a,b,c  

^a CNRS   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Catenins; Endothelial cells; Internalization; Permeability; Phosphorylation; Vascular barrier; VE cadherin; VEGF

Indexed keywords

VASCULAR ENDOTHELIAL CADHERIN;

CELL INTERACTION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM; INTERNALIZATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

CATENINS; ENDOTHELIAL CELLS; INTERNALIZATION; PERMEABILITY; PHOSPHORYLATION; VASCULAR BARRIER; VE-CADHERIN; VEGF;

ANTIGENS, CD; BETA CATENIN; CADHERINS; CELL COMMUNICATION; CELL MEMBRANE PERMEABILITY; ENDOTHELIAL CELLS; HUMANS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84894503121     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.27330     Document Type: Review

References (105)

1. Gavard J. Breaking the VE-cadherin bonds. FEBS Lett 2009; 583:1-6; PMID:19059243; http://dx.doi.org/10.1016/j.febslet.2008.11.032
2. Prandini MH, Dreher I, Bouillot S, Benkerri S, Moll T, Huber P. The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Oncogene 2005; 24:29923001; PMID:15735710; http://dx.doi.org/10.1038/sj.onc.1208483
3. Gory S, Vernet M, Laurent M, Dejana E, Dalmon J, Huber P. The vascular endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice. Blood 1999; 93:184-92; PMID:9864160 (Pubitemid 29019402)
4. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oosthuyse B, Dewerchin M, et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999; 98:14757; PMID:10428027; http://dx.doi.org/10.1016/S0092-8674(00)81010-7
5. Vittet D, Buchou T, Schweitzer A, Dejana E, Huber P. Targeted null-mutation in the vascular endothelialcadherin gene impairs the organization of vascularlike structures in embryoid bodies. Proc Natl Acad Sci U S A 1997; 94:6273-8; PMID:9177207; http://dx.doi.org/10.1073/pnas.94.12.6273 (Pubitemid 27270674)
6. Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, Dejana E, Drake CJ. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 2005; 105:2771-6; PMID:15604224; http://dx.doi.org/10.1182/blood-2004-06-2244 (Pubitemid 40446268)
7. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, Lampugnani MG, MartinPadura I, Stoppacciaro A, Ruco L, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A 1999; 96:9815-20; PMID:10449777; http://dx.doi.org/10.1073/pnas.96.17.9815 (Pubitemid 29398815)
8. Gavard J, Gutkind JS. VEGF controls endothelialcell permeability by promoting the beta-arrestindependent endocytosis of VE-cadherin. Nat Cell Biol 2006; 8:1223-34; PMID:17060906; http://dx.doi.org/10.1038/ncb1486 (Pubitemid 44660587)
9. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S, Dejana E. Endothelial adherens junctions control tight junctions by VE-cadherinmediated upregulation of claudin-5. Nat Cell Biol 2008; 10:923-34; PMID:18604199; http://dx.doi.org/10.1038/ncb1752
10. Heupel WM, Efthymiadis A, Schlegel N, Müller T, Baumer Y, Baumgartner W, Drenckhahn D, Waschke J. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo. J Cell Sci 2009; 122:1616-25; PMID:19420236; http://dx.doi.org/10.1242/ jcs.040212
11. Hebda JK, Leclair HM, Azzi S, Roussel C, Scott MG, Bidére N, Gavard J. The C-terminus region of ?-arrestin1 modulates VE-cadherin expression and endothelial cell permeability. Cell Commun Signal 2013; 11:37; PMID:23714586; http://dx.doi.org/10.1186/1478-811X-11-37
12. Gavard J, Gutkind JS. VE-cadherin and claudin-5: it takes two to tango. Nat Cell Biol 2008; 10:8835; PMID:18670447; http://dx.doi.org/10.1038/ncb0808- 883
13. Giampietro C, Taddei A, Corada M, SarraFerraris GM, Alcalay M, Cavallaro U, Orsenigo F, Lampugnani MG, Dejana E. Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells. Blood 2012; 119:2159-70; PMID:22246030; http://dx.doi.org/10.1182/blood-2011-09-381012
14. Broman MT, Kouklis P, Gao X, Ramchandran R, Neamu RF, Minshall RD, Malik AB. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex. Circ Res 2006; 98:73-80; PMID:16322481; http://dx.doi.org/10.1161/01. RES.0000198387.44395.e9 (Pubitemid 43970205)
15. Huveneers S, Oldenburg J, Spanjaard E, van der Krogt G, Grigoriev I, Akhmanova A, Rehmann H, de Rooij J. Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling. J Cell Biol 2012; 196:641-52; PMID:22391038; http://dx.doi.org/10.1083/jcb.201108120
16. Chervin-Petinot A, Courcon M, Almagro S, Nicolas A, Grichine A, Grunwald D, Prandini MH, Huber P, Gulino-Debrac D. Epithelial protein lost in neoplasm (EPLIN) interacts with ?-catenin and actin filaments in endothelial cells and stabilizes vascular capillary network in vitro. J Biol Chem 2012; 287:7556-72; PMID:22194609; http://dx.doi.org/10.1074/jbc. M111.328682
17. Noda K, Zhang J, Fukuhara S, Kunimoto S, Yoshimura M, Mochizuki N. Vascular endothelialcadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alphaand beta-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells. Mol Biol Cell 2010; 21:58496; PMID:20032304; http://dx.doi.org/10.1091/mbc.E09-07-0580
18. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 2004; 5:26170; PMID:15071551; http://dx.doi.org/10.1038/nrm1357
19. Timmerman I, Hoogenboezem M, Bennett AM, Geerts D, Hordijk PL, van Buul JD. The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of ?-catenin phosphorylation. Mol Biol Cell 2012; 23:4212-25; PMID:22956765; http://dx.doi.org/10.1091/mbc. E12-01-0038
20. Corada M, Nyqvist D, Orsenigo F, Caprini A, Giampietro C, Taketo MM, Iruela-Arispe ML, Adams RH, Dejana E. The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev Cell 2010; 18:938-49; PMID:20627076; http://dx.doi.org/10.1016/j.devcel.2010.05. 006
21. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, et al. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 2008; 183:409-17; PMID:18955553; http://dx.doi.org/10.1083/jcb.200806024
22. Paolinelli R, Corada M, Ferrarini L, Devraj K, Artus C, Czupalla CJ, Rudini N, Maddaluno L, Papa E, Engelhardt B, et al. Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro. PLoS One 2013; 8:e70233; PMID:23940549; http://dx.doi.org/10.1371/journal.pone.0070233
23. Nottebaum AF, Cagna G, Winderlich M, Gamp AC, Linnepe R, Polaschegg C, Filippova K, Lyck R, Engelhardt B, Kamenyeva O, et al. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med 2008; 205:292945; PMID:19015309; http://dx.doi.org/10.1084/jem.20080406
24. Xiao K, Garner J, Buckley KM, Vincent PA, Chiasson CM, Dejana E, Faundez V, Kowalczyk AP. p120Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Mol Biol Cell 2005; 16:5141-51; PMID:16120645; http://dx.doi.org/ 10.1091/mbc.E05-05-0440 (Pubitemid 41566827)
25. Xiao K, Allison DF, Buckley KM, Kottke MD, Vincent PA, Faundez V, Kowalczyk AP. Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells. J Cell Biol 2003; 163:535-45; PMID:14610056; http://dx.doi.org/10.1083/jcb.200306001 (Pubitemid 37429867)
26. Nanes BA, Chiasson-MacKenzie C, Lowery AM, Ishiyama N, Faundez V, Ikura M, Vincent PA, Kowalczyk AP. p120-catenin binding masks an endocytic signal conserved in classical cadherins. J Cell Biol 2012; 199:365-80; PMID:23071156; http://dx.doi.org/10.1083/jcb.201205029
27. Herron CR, Lowery AM, Hollister PR, Reynolds AB, Vincent PA. p120 regulates endothelial permeability independently of its NH2 terminus and Rho binding. Am J Physiol Heart Circ Physiol 2011; 300:H3648; PMID:20971762; http://dx.doi.org/10.1152/ajpheart.00812.2010
28. Iden S, Rehder D, August B, Suzuki A, WolburgBuchholz K, Wolburg H, Ohno S, Behrens J, Vestweber D, Ebnet K. A distinct PAR complex associates physically with VE-cadherin in vertebrate endothelial cells. EMBO Rep 2006; 7:123946; PMID:17057644; http://dx.doi.org/10.1038/sj.embor.7400819
29. Lampugnani MG, Orsenigo F, Rudini N, Maddaluno L, Boulday G, Chapon F, Dejana E. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci 2010; 123:107380; PMID:20332120; http://dx.doi.org/10.1242/ jcs.059329
30. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, Mochizuki N. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 2005; 25:13646; PMID:15601837; http://dx.doi.org/10.1128/MCB.25.1.136-146.2005
31. Kooistra MR, Corada M, Dejana E, Bos JL. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 2005; 579:496672; PMID:16115630; http://dx.doi.org/10.1016/j.febslet.2005.07.080
32. Pannekoek WJ, van Dijk JJ, Chan OY, Huveneers S, Linnemann JR, Spanjaard E, Brouwer PM, van der Meer AJ, Zwartkruis FJ, Rehmann H, et al. Epac1 and PDZ-GEF cooperate in Rap1 mediated endothelial junction control. Cell Signal 2011; 23:205664; PMID:21840392; http://dx.doi.org/10.1016/j.cellsig.2011.07.022
33. Wimmer R, Cseh B, Maier B, Scherrer K, Baccarini M. Angiogenic sprouting requires the fine tuning of endothelial cell cohesion by the Raf-1/Rok- complex. Dev Cell 2012; 22:158-71; PMID:22209329; http://dx.doi.org/10.1016/j.devcel. 2011.11.012
34. Sakurai A, Fukuhara S, Yamagishi A, Sako K, Kamioka Y, Masuda M, Nakaoka Y, Mochizuki N. MAGI-1 is required for Rap1 activation upon cell-cell contact and for enhancement of vascular endothelial cadherin-mediated cell adhesion. Mol Biol Cell 2006; 17:966-76; PMID:16339077; http://dx.doi.org/10.1091/mbc.E05-07- 0647 (Pubitemid 43191128)
35. Le Guelte A, Galan-Moya EM, Dwyer J, Treps L, Kettler G, Hebda JK, Dubois S, Auffray C, Chneiweiss H, Bidere N, et al. Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation. J Cell Sci 2012; 125:4137-46; PMID:22685328; http://dx.doi.org/10.1242/jcs.108282
36. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 2002; 21:4885-95; PMID:12234928; http://dx.doi.org/10.1093/emboj/cdf497
37. Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 2003; 161:793-804; PMID:12771128; http://dx.doi.org/10.1083/jcb.200209019 (Pubitemid 36648762)
38. Spring K, Chabot C, Langlois S, Lapointe L, Trinh NT, Caron C, Hebda JK, Gavard J, Elchebly M, Royal I. Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation. Blood 2012; 120:274556; PMID:22898603; http://dx.doi.org/10.1182/blood-2011-12-398040
39. Nakamura Y, Patrushev N, Inomata H, Mehta D, Urao N, Kim HW, Razvi M, Kini V, Mahadev K, Goldstein BJ, et al. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Circ Res 2008; 102:1182-91; PMID:18451337; http://dx.doi.org/10.1161/CIRCRESAHA.107.167080
40. Harris ES, Nelson WJ. VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Curr Opin Cell Biol 2010; 22:6518; PMID:20708398; http://dx.doi.org/10.1016/j.ceb.2010.07.006
41. Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 2006; 174:593-604; PMID:16893970; http://dx.doi.org/10.1083/jcb.200602080 (Pubitemid 44231870)
42. Gaengel K, Niaudet C, Hagikura K, Lavina B, Muhl L, Hofmann JJ, Ebarasi L, Nystrom S, Rymo S, Chen LL, et al. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev Cell 2012; 23:587-99; PMID:22975327; http://dx.doi.org/10.1016/j.devcel.2012.08.005
43. Abraham S, Yeo M, Montero-Balaguer M, Paterson H, Dejana E, Marshall CJ, Mavria G. VE-Cadherinmediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation. Curr Biol 2009; 19:668-74; PMID:19345098; http://dx.doi.org/10.1016/j.cub.2009.02.057
44. Cook BD, Ferrari G, Pintucci G, Mignatti P. TGFbeta1 induces rearrangement of FLK-1-VE-cadherinbetacatenin complex at the adherens junction through VEGF-mediated signaling. J Cell Biochem 2008; 105:1367-73; PMID:18980215; http://dx.doi.org/10.1002/jcb.21935
45. Venkatesh D, Fredette N, Rostama B, Tang Y, Vary CP, Liaw L, Urs S. RhoA-mediated signaling in Notch-induced senescence-like growth arrest and endothelial barrier dysfunction. Arterioscler Thromb Vasc Biol 2011; 31:876-82; PMID:21273559; http://dx.doi.org/10.1161/ATVBAHA.110.221945
46. Hayashi M, Majumdar A, Li X, Adler J, Sun Z, Vertuani S, Hellberg C, Mellberg S, Koch S, Dimberg A, et al. VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nat Commun 2013; 4:1672; PMID:23575676; http://dx.doi.org/10.1038/ncomms2683
47. Weis S, Shintani S, Weber A, Kirchmair R, Wood M, Cravens A, McSharry H, Iwakura A, Yoon YS, Himes N, et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 2004; 113:88594; PMID:15067321
48. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 2008; 10:527-37; PMID:18425119; http://dx.doi.org/10. 1038/ncb1715 (Pubitemid 351627372)
49. Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, Shibuya M, Takakura N, Koh GY, Mochizuki N. Differential function of Tie2 at cellcell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 2008; 10:51326; PMID:18425120; http://dx.doi.org/10.1038/ncb1714
50. Murakami M, Nguyen LT, Zhuang ZW, Moodie KL, Carmeliet P, Stan RV, Simons M. The FGF system has a key role in regulating vascular integrity. J Clin Invest 2008; 118:3355-66; PMID:18776942; http://dx.doi.org/10.1172/JCI35298
51. Rudini N, Felici A, Giampietro C, Lampugnani M, Corada M, Swirsding K, Garré M, Liebner S, Letarte M, ten Dijke P, et al. VE-cadherin is a critical endothelial regulator of TGF-beta signalling. EMBO J 2008; 27:993-1004; PMID:18337748; http://dx.doi.org/10.1038/emboj.2008.46 (Pubitemid 351508155)
52. Winderlich M, Keller L, Cagna G, Broermann A, Kamenyeva O, Kiefer F, Deutsch U, Nottebaum AF, Vestweber D. VE-PTP controls blood vessel development by balancing Tie-2 activity. J Cell Biol 2009; 185:657-71; PMID:19451274; http://dx.doi.org/10.1083/jcb.200811159
53. Lampugnani MG, Zanetti A, Breviario F, Balconi G, Orsenigo F, Corada M, Spagnuolo R, Betson M, Braga V, Dejana E. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol Biol Cell 2002; 13:117589; PMID:11950930; http://dx.doi.org/10.1091/mbc.01-07-0368
54. Birukova AA, Tian Y, Dubrovskyi O, Zebda N, Sarich N, Tian X, Wang Y, Birukov KG. VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost. J Cell Physiol 2012; 227:3405-16; PMID:22213015; http://dx.doi.org/10.1002/jcp.24041
55. Braga VM, Del Maschio A, Machesky L, Dejana E. Regulation of cadherin function by Rho and Rac: modulation by junction maturation and cellular context. Mol Biol Cell 1999; 10:9-22; PMID:9880323; http://dx.doi.org/10.1091/mbc.10.1.9 (Pubitemid 29156923)
56. Komarova YA, Huang F, Geyer M, Daneshjou N, Garcia A, Idalino L, Kreutz B, Mehta D, Malik AB. VE-cadherin signaling induces EB3 phosphorylation to suppress microtubule growth and assemble adherens junctions. Mol Cell 2012; 48:914-25; PMID:23159740; http://dx.doi.org/10.1016/j.molcel.2012.10.011
57. Potter MD, Barbero S, Cheresh DA. Tyrosine phosphorylation of VE-cadherin prevents binding of p120and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 2005; 280:3190612; PMID:16027153; http://dx.doi.org/10.1074/ jbc. M505568200
58. Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, Sigismund S, Ristagno G, Maddaluno L, Koh GY, Franco D, et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 2012; 3:1208; PMID:23169049; http://dx.doi.org/10.1038/ncomms2199
59. Wallez Y, Cand F, Cruzalegui F, Wernstedt C, Souchelnytskyi S, Vilgrain I, Huber P. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 2007; 26:1067-77; PMID:16909109; http://dx.doi.org/10.1038/sj.onc.1209855
60. Turowski P, Martinelli R, Crawford R, Wateridge D, Papageorgiou AP, Lampugnani MG, Gamp AC, Vestweber D, Adamson P, Dejana E, et al. Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. J Cell Sci 2008; 121:2937; PMID:18096689; http://dx.doi.org/10.1242/jcs.022681
61. Schulte D, Küppers V, Dartsch N, Broermann A, Li H, Zarbock A, Kamenyeva O, Kiefer F, Khandoga A, Massberg S, et al. Stabilizing the VE-cadherincatenin complex blocks leukocyte extravasation and vascular permeability. EMBO J 2011; 30:415770; PMID:21857650; http://dx.doi.org/10.1038/ emboj.2011.304
62. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 2008; 14:25-36; PMID:18194650; http://dx.doi.org/10.1016/j.devcel.2007.10.019
63. Weis S, Cui J, Barnes L, Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 2004; 167:223-9; PMID:15504909; http://dx.doi.org/10.1083/jcb. 200408130 (Pubitemid 39435066)
64. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 1999; 4:91524; PMID:10635317; http://dx.doi.org/10.1016/S1097-2765(00)80221-X
65. Adam AP, Sharenko AL, Pumiglia K, Vincent PA. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. J Biol Chem 2010; 285:7045-55; PMID:20048167; http://dx.doi.org/10.1074/jbc. M109.079277
66. Zhao X, Peng X, Sun S, Park AY, Guan JL. Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development. J Cell Biol 2010; 189:955-65; PMID:20530207; http://dx.doi.org/10.1083/jcb.200912094
67. Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, Lim ST, Tomar A, Tancioni I, Uryu S, et al. VEGF-induced vascular permeability is mediated by FAK. Dev Cell 2012; 22:146-57; PMID:22264731; http://dx.doi.org/10.1016/j. devcel.2011.11.002
68. Kronstein R, Seebach J, Grossklaus S, Minten C, Engelhardt B, Drab M, Liebner S, Arsenijevic Y, Taha AA, Afanasieva T, et al. Caveolin-1 opens endothelial cell junctions by targeting catenins. Cardiovasc Res 2012; 93:130-40; PMID:21960684; http://dx.doi.org/10.1093/cvr/cvr256
69. Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005; 437:426-31; PMID:16163360; http://dx.doi.org/10.1038/nature03952 (Pubitemid 41613506)
70. Conway DE, Schwartz MA. Flow-dependent cellular mechanotransduction in atherosclerosis. J Cell Sci 2013; 126:5101-9; PMID:24190880; http://dx.doi.org/10.1242/jcs.138313
71. Conway DE, Breckenridge MT, Hinde E, Gratton E, Chen CS, Schwartz MA. Fluid shear stress on endothelial cells modulates mechanical tension across VE-cadherin and PECAM-1. Curr Biol 2013; 23:1024-30; PMID:23684974; http://dx.doi.org/10.1016/j.cub.2013.04.049
72. Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 2002; 39:187-99; PMID:12747959; http://dx.doi.org/10.1016/S1537-1891(03)00008-9 (Pubitemid 37492962)
73. van Nieuw Amerongen GP, van Delft S, Vermeer MA, Collard JG, van Hinsbergh VW. Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ Res 2000; 87:335-40; PMID:10948069; http://dx.doi.org/10.1161/01.RES.87.4.335 (Pubitemid 30655976)
74. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86:279-367; PMID:16371600; http://dx.doi.org/10. 1152/physrev.00012.2005
75. Wójciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 2001; 114:1343-55; PMID:11257000 (Pubitemid 32409470)
76. Nelson CM, Pirone DM, Tan JL, Chen CS. Vascular endothelial-cadherin regulates cytoskeletal tension, cell spreading, and focal adhesions by stimulating RhoA. Mol Biol Cell 2004; 15:2943-53; PMID:15075376; http://dx.doi.org/10.1091/mbc.E03-10-0745 (Pubitemid 38691881)
77. Le Guelte A, Dwyer J, Gavard J. Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer. Biol Cell 2011; 103:593-605; PMID:22054419; http://dx.doi.org/10.1042/BC20110069
78. Vandenbroucke St Amant E, Tauseef M, Vogel SM, Gao XP, Mehta D, Komarova YA, Malik AB. PKC activation of p120-catenin serine 879 phosphoswitch disassembles VE-cadherin junctions and disrupts vascular integrity. Circ Res 2012; 111:73949; PMID:22798526; http://dx.doi.org/10.1161/CIRCRESAHA.112.269654
79. Troyanovsky RB, Sokolov EP, Troyanovsky SM. Endocytosis of cadherin from intracellular junctions is the driving force for cadherin adhesive dimer disassembly. Mol Biol Cell 2006; 17:3484-93; PMID:16760429; http://dx.doi.org/ 10.1091/mbc.E06-03-0190 (Pubitemid 44156442)
80. Li R, Ren M, Chen N, Luo M, Zhang Z, Wu J. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions. PLoS One 2012; 7:e37195; PMID:22606350; http://dx.doi.org/10.1371/journal.pone. 0037195
81. Yoshioka K, Yoshida K, Cui H, Wakayama T, Takuwa N, Okamoto Y, Du W, Qi X, Asanuma K, Sugihara K, et al. Endothelial PI3K-C2?, a class II PI3K, has an essential role in angiogenesis and vascular barrier function. Nat Med 2012; 18:15609; PMID:22983395; http://dx.doi.org/10.1038/nm.2928
82. Chiasson CM, Wittich KB, Vincent PA, Faundez V, Kowalczyk AP. p120-catenin inhibits VE-cadherin internalization through a Rho-independent mechanism. Mol Biol Cell 2009; 20:1970-80; PMID:19211843; http://dx.doi.org/10. 1091/mbc.E08-07-0735
83. Dwyer J, Hebda JK, Le Guelte A, Galan-Moya EM, Smith SS, Azzi S, Bidere N, Gavard J. Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS One 2012; 7:e45562; PMID:23029099; http://dx.doi.org/10.1371/journal.pone.0045562
84. Dwyer J, Le Guelte A, Galan Moya EM, Sumbal M, Carlotti A, Douguet L, Gutkind JS, Grange PA, Dupin N, Gavard J. Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor. Oncogene 2011; 30:190-200; PMID:20818438; http://dx.doi.org/10.1038/onc.2010.411
85. Gavard J, Hou X, Qu Y, Masedunskas A, Martin D, Weigert R, Li X, Gutkind JS. A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol 2009; 29:2469-80; PMID:19255141; http://dx.doi.org/10.1128/MCB.01304-08
86. Cain RJ, Vanhaesebroeck B, Ridley AJ. The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. J Cell Biol 2010; 188:863-76; PMID:20308428; http://dx.doi.org/10.1083/jcb.200907135
87. Jones CA, London NR, Chen H, Park KW, Sauvaget D, Stockton RA, Wythe JD, Suh W, LarrieuLahargue F, Mukouyama YS, et al. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med 2008; 14:448-53; PMID:18345009; http://dx.doi.org/10.1038/nm1742 (Pubitemid 351499393)
88. Cowan CE, Kohler EE, Dugan TA, Mirza MK, Malik AB, Wary KK. Kruppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier function. Circ Res 2010; 107:95966; PMID:20724706; http://dx.doi.org/10. 1161/CIRCRESAHA.110.219592
89. Oas RG, Xiao K, Summers S, Wittich KB, Chiasson CM, Martin WD, Grossniklaus HE, Vincent PA, Reynolds AB, Kowalczyk AP. p120-Catenin is required for mouse vascular development. Circ Res 2010; 106:941-51; PMID:20110533; http://dx.doi.org/10.1161/CIRCRESAHA.109.207753
90. Yuan L, Le Bras A, Sacharidou A, Itagaki K, Zhan Y, Kondo M, Carman CV, Davis GE, Aird WC, Oettgen P. ETS-related gene (ERG) controls endothelial cell permeability via transcriptional regulation of the claudin 5 (CLDN5) gene. J Biol Chem 2012; 287:6582-91; PMID:22235125; http://dx.doi.org/10.1074/jbc.M111. 300236
91. Le Bras A, Lionneton F, Mattot V, Leliévre E, Caetano B, Spruyt N, Soncin F. HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites. Oncogene 2007; 26:7480-9; PMID:17563748; http://dx.doi.org/ 10.1038/sj.onc.1210566 (Pubitemid 350158718)
92. Birdsey GM, Dryden NH, Amsellem V, Gebhardt F, Sahnan K, Haskard DO, Dejana E, Mason JC, Randi AM. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood 2008; 111:3498-506; PMID:18195090; http://dx.doi.org/10.1182/blood-2007-08-105346
93. Deleuze V, Chalhoub E, El-Hajj R, Dohet C, Le Clech M, Couraud PO, Huber P, Mathieu D. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol Cell Biol 2007; 27:2687-97; PMID:17242194; http://dx.doi.org/10.1128/MCB.00493-06 (Pubitemid 46581358)
94. Franco CA, Mericskay M, Parlakian A, Gary-Bobo G, Gao-Li J, Paulin D, Gustafsson E, Li Z. Serum response factor is required for sprouting angiogenesis and vascular integrity. Dev Cell 2008; 15:44861; PMID:18804439; http://dx.doi.org/10.1016/j.devcel.2008.07.019
95. Costa G, Mazan A, Gandillet A, Pearson S, Lacaud G, Kouskoff V. SOX7 regulates the expression of VE-cadherin in the haemogenic endothelium at the onset of haematopoietic development. Development 2012; 139:1587-98; PMID:22492353; http://dx.doi.org/10.1242/dev.071282
96. Young JA, Ting KK, Li J, Moller T, Dunn L, Lu Y, Moses J, Prado-Lourenco L, Khachigian LM, Ng M, et al. Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherinrestricted miRNA antagonists of miR-27. Blood 2013; 122:2911-9; http://dx.doi.org/10.1182/blood-2012-12-473017
97. Mishra R, Singh SK. HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells. The Journal of neuroscience: the official journal of the Society for Neuroscience 2013; 33:5992-6000.
98. Muramatsu F, Kidoya H, Naito H, Sakimoto S, Takakura N. microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin. Oncogene 2013; 32:414-21; PMID:22391569; http://dx.doi.org/10.1038/ onc.2012.68
99. Lalwani MK, Sharma M, Singh AR, Chauhan RK, Patowary A, Singh N, Scaria V, Sivasubbu S. Reverse genetics screen in zebrafish identifies a role of miR142a-3p in vascular development and integrity. PLoS One 2012; 7:e52588; PMID:23285103; http://dx.doi.org/10.1371/journal.pone.0052588
100. Kane NM, Howard L, Descamps B, Meloni M, McClure J, Lu R, McCahill A, Breen C, Mackenzie RM, Delles C, et al. Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells 2012; 30:643-54; PMID:22232059; http://dx.doi.org/10.1002/ stem.1026
101. Xiao K, Allison DF, Kottke MD, Summers S, Sorescu GP, Faundez V, Kowalczyk AP. Mechanisms of VE-cadherin processing and degradation in microvascular endothelial cells. J Biol Chem 2003; 278:19199-208; PMID:12626512; http://dx.doi.org/10.1074/jbc.M211746200 (Pubitemid 36799311)
102. Mansouri M, Rose PP, Moses AV, Früh K. Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus. J Virol 2008; 82:9615-28; PMID:18667499; http://dx.doi.org/10.1128/JVI.02633-07
103. Schulz B, Pruessmeyer J, Maretzky T, Ludwig A, Blobel CP, Saftig P, Reiss K. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res 2008; 102:1192-201; PMID:18420943; http://dx.doi.org/10.1161/CIRCRESAHA.107.169805
104. Miyazaki T, Taketomi Y, Takimoto M, Lei XF, Arita S, Kim-Kaneyama JR, Arata S, Ohata H, Ota H, Murakami M, et al. m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis. Circulation 2011; 124:252232; PMID:22064597; http://dx.doi.org/10.1161/CIRCULATIONAHA.111.021675
105. Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005; 437:497-504; PMID:16177780; http://dx.doi.org/10.1038/nature03987 (Pubitemid 41613541)